Seeking to combat COVID-19 with an oral RNA viral polymerase inhibitor. - Atea Pharmaceuticals

Retrieved on: 2022-05-21 18:18:50

Tags for this article:

Click the tags to see associated articles and topics

Seeking to combat COVID-19 with an oral RNA viral polymerase inhibitor. - Atea Pharmaceuticals. View article details on hiswai:

Excerpt

Built on our purine nucleotide prodrug platform, bemnifosbuvir (AT-527) is an orally administered, direct-acting antiviral therapy for the ...

Article found on: ateapharma.com